UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Colorectal cancer in inflammatory bowel disease: review of the evidence

Keller, DS; Windsor, A; Cohen, R; Chand, M; (2019) Colorectal cancer in inflammatory bowel disease: review of the evidence. Techniques in Coloproctology , 23 (1) pp. 3-13. 10.1007/s10151-019-1926-2.

[img] Text
Keller_IBD CRC Review Rev 3.pdf - Accepted version
Access restricted to UCL open access staff until 31 January 2020.

Download (226kB)

Abstract

Inflammatory bowel disease (IBD)-related colorectal cancer (CRC) is responsible for approximately 2% of the annual mortality from CRC overall, but 10–15% of the annual deaths in IBD patients. IBD-related CRC patients are also affected at a younger age than sporadic CRC patients, and have a 5-year survival rate of 50%. Despite optimal medical treatment, the chronic inflammatory state inherent in IBD increases the risk for high-grade dysplasia and CRC, with additional input from genetic and environmental risk factors and the microbiome. Recognizing risk factors, implementing appropriate surveillance, and identifying high-risk patients are key to managing the CRC risk in IBD patients. Chemoprevention strategies exist, and studies evaluating their efficacy are underway. Once dysplasia or invasive cancer is diagnosed, appropriate surgical resection and postoperative treatment and surveillance are necessary. Here, we discuss the current state of IBD-related CRC, prevalence, risk factors, and evidence for surveillance, prophylaxis, and treatment recommendations.

Type: Article
Title: Colorectal cancer in inflammatory bowel disease: review of the evidence
DOI: 10.1007/s10151-019-1926-2
Publisher version: https://doi.org/10.1007/s10151-019-1926-2
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: Inflammatory bowel disease, Crohn’s disease, Ulcerative colitis, Colorectal cancer, Screening, Colonoscopy, Chemoprophylaxis
UCL classification: UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Surgery and Interventional Sci
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Surgery and Interventional Sci > Department of Targeted Intervention
URI: https://discovery.ucl.ac.uk/id/eprint/10071859
Downloads since deposit
1Download
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item